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DISTURBED SECRETION OF ATRIAL NATRIURETIC PEPTIDE IN 
PERSISTENT ATRIAL STANDSTILL: ENDOCRINOLOGICAL SILENCI 
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Teruo Takano, M.D.. Hirokazu Hayakawa, M&D., 
Nippoi Mld;lal School, Tokyo, Japan 
Persistent atria1 standstill (PAS) is a very rare 
pathophysiological condition, the diagnosis of which 
is establ ished when both electrical and mechanical si- 
lence of the atrium are confirmed. To test the hypothe- 
sis that secretion of atria1 natriuretic peptide (ANP) 
is disturbed in PAS, we investigated the response of 
ANP secretion and other neurohormonal factors during 
exercise in three patients with rate responsive (RR-)VVI 
pacemaker implanted for confirmed PAS, and compared the 
results with those observed in normals (N,n=8) and pa- 
tients with WYY!(n=S) or RR-AAI(n=6) pacemakers im- 
planted for confirmed sick sinus syndrome (SSS). SSS(RR- 
VVI) patients displayed marked significant elevation 
of a-hANP secretion both before and during ex. (122.5i 
14.8, 207.5i8.3 pgjml) as compared with those of SSS(RR- 
AAI) pts. (55.0i14.1 *, 116.4*51.5*) and N (18.9&9.8-, 
30.8i19.2m), which indicated unphysiological increase 
in atria1 volume/pressure overload in RR-VVI pacing be- 
cause of lack of -AV synchrony. However PAS(RR-VVI) pts 
disolaved undetectable (lops/ml) secretion of a-hANP - -r ---- 
as well as lower levels ‘of'cycfic GMP both before and 
during ex. Changes in plasma NE and E during ex. were 
similar in PAS pts and other groups. This study indi- 
cated the existence of endocrinological silence accompa- 
nying electrical and mechanical silence of atrium, which 
could constitute a third diagnostic clue in PAS. 
(*p<O.D5,~p<O.OD5,~p~O.O01) 
ATRIAL NATRIuRBnC PACIQR IS A VASODILAT'OR WITR NO 
DIRRCT HTOCARDIAL BPPRCT IN SIVRS 
l4arc J. Semi ran ND, Constantine N. Aroney RBBS 
mini&DTACC, Rouard C. Rerraann HD &CC. 
Charles A. Boucher MD #AC& Mchael A. Pifer RD PA&+, 
Massachusetts General liospital and Harvard Medical 
School, Boston, HA 
To assess the effects of rtr?al natriuretic factor 
(ANP) on LV systolic and diastolic function, ve 
administered nitroprusside (mP) and ANF to 10 pts vith 
hypertension. LV micromanometer pressure and 
radionuclide volumwz vere obtained at baseline. on 
NTP (63$13 ug/min), during a second baseline-period, and 
on ANF (0.4020.07 ug/kg/lain). Heart rate and Dlasma 
norepinephrine level increased and LVgDP and sistemic 
vascular resistance fell similarly on NTP and ANF. 
Cardiac index did not change. Hean arterial pressure 
(HAP, madIg), LV dP/dt at developed pressure 40 xunIig 
(dP/dtDP40, amRg/s), tlae constant of isovolumic 
relaxation (T, as) and peak LV filling rate (PPR, ml/s) 
were (*p<O.OS vs. preceding baseline, 
NW): 
dP/d tDP40 T 
Baseline 
NTP 
136 3061 44 46?3 
92*5* 
Baseline 
1179fB8 
114i5 
276231 
ANP 
1063kS3 
99&5* 
316k2B 
1175*79 42&3* 336k41 
There vas no shift in the LV end-svstalic 
-w------ 
pressure-volume relation on ANP compared to baseline and 
NTP. The LV diastolic pressure-volume relation shifted 
dovnvard in only one pt on ANP and in one pt on NTP. 
Conclusions: (1) The hemodynamic effects of ANF are 
similar to ,those of NTP in-hypertensive patients. (2) 
ANP acts as a “pure” vasodilator vithout direct effects 
on myocardial systolic or diastolic function. 
EMQDYNAM~C AND CDRDNARY EF 
ORONARII ATRIAL NA~RIURE~~~ 
Herrmann, M.D., F.A.C.C. Univers 
We evaluated the direct myocardial and coronary effects of syntbctic 
(rat 103-126) aorial natriurede peptide (ANP) by infusi . 
concentrations directly into le left coronary vnery of 8 
normal LV function and left coronary angiograms. 
hemodynamic parameters and hi-fidelity LV pressure were recorded at 
each dose and indexes of LV conlractilc and diastolic fun&on were 
calculaled. Coronary angiogrRms a1 baseline and highest dose of ANP 
were compared by quantitative image analysis techniques. 
At Ihe highest dose administered (67 f 5 mcglmin). ANP decreased 
mean pulmon tery (-36%). pulmonary wedge 
diastolic (-Se V end-systolic (-11%). and me 
pressures, an monary vascular resistance 
Cardiac output and systemic vascular resistance were 
heart rate and peak positive dP/dt both increased 
pcO.01). Peak negative dP/dt and Ihc time constant 
LV relaxation (log mahod) fell at the highest dose of ANP, although 
time constanls calculalcd by olhcr less load-sensitive methods were 
unchanged. Lower doses of inlracoronary ANP which did not change LV 
load or heart rate had no effect on indexes of systolic or diastolic func- 
tion d:spite a presumably high intramyocardial concentration of ANP. 
The effeczn of ANP on epicardial coronary artery diameter and cross- 
seclional area in 40 segments of the left anterior descending (LAD) and 
umflcx (LCX) car ries 1: 
LAD diamctcr (mm): 2.05 f 0.19 2.61 f 0.21 27 f 4 0.0001 
area (mm2): 3.97 f 0.75 6.12 f 1.02 54 f 12 0.0001 
LM diameter (mm): 2.11 f 0.16 2.65 f 0.18 26 f 4 0.0001 
area (mm2): 3.80 f 0.60 5.86 f 0.76 54 f 11 0.0004 
Conclusions: 1) ANP is a systemic vasodilator without direct 
myocardial effects in normal subjects; 2) ANP dilates large epicardial 
coronary arlerics in man. 
EFFECTSOTS C FACI’QR 
VENTRICULAR CONTR AXATIQN 
ON LE 
1N MAN. 
Gordon W. Moe, M.D., F.A.C.C., University 
Previous studies have yielded conflicting, data on the irs 
vivo effect nf atria1 natriuretic factor (ANF) on LV 
contractility and little information is available on its 
effect on LV relaxation. Accordingly, we studied the effects 
of synthetic ANF (99-126 ANF: 0.2 ug/kg followed by 0.07 
>g/kg/min for 30 minutes) on isovolumetric indicEs of LV 
contractility and relaxation in 8 Pt with normal LV systolic 
function during routine cardiac catheterization. Data ( 
pooled SD from ANOVA) for LV systolic and diastolic pressures 
(LVS, LVD, mmHg), 1st derivative of LV prmsure, norma/ixed to 
afterload and preload [dp/dt/p; (dp{dt)/DWO, set’ ] and 
indices of relaxation (-dp/dt/p, set’ ; the relaxation time 
constant tau, msec) at baseline, 30 minutes of ANF infusion 
(30 min), and 30 minutes at recovery are shown. *p<O.OS versus 
baseline values, 
Baseline 52 
30 min 
9.8 
Synthetic ANF lowered LVD, but id not change the 
normalized indices of LV contractility or relaxation. 
Conclusions: I) ANF reduces preload, but does not alter LV 
relaxation. 2) ANF has no direct in vivo effect on LV 
inotropic state. 
